Recombinant Mouse Antibody clone KEL10, which is specific to HIV-1. The purified antibody showed equivalent binding to ELDKWA as well as the variants ELDSWA, ALDKWQ, ELNKWQ and ELDTWA at antibody concentrations ranging from 65 μM to 0.5 μM.
Figure 1 Generation of mAb KEL10.
Screening of cross-reacting monoclonal hybridomas generated against ELDKWA by ELISA. KEL10 was used for further studies due to its ability to secrete higher levels of antibody and also demonstrating higher cross-reactivity with different epitopes.
Bhowmick, A., & Salunke, D. M. (2012). Limited conformational flexibility in the paratope may be responsible for degenerate specificity of HIV epitope recognition. International immunology, 25(2), 77-90.
Figure 2 ELISA-based binding analysis of KEL10.
(A) Binding of pure KEL10 to immobilized immunizing peptide and its variants in ELISA, as a function of antibody concentration. A total of 2 μg of peptide–BSA conjugate was immobilized as antigen for ELISA. BSA was used as a control and the average background OD (optical density) at 490nm was 0.07. All the peptide epitopes demonstrated equivalent binding to KEL10. (B) Binding of KEL10 to gp41 using a clinical ELISA kit. KEL10 showed comparable binding to 4E10 and to the gp41 core protein coated in the ELISA plate (antibody concentration: 0.25 uM).
Bhowmick, A., & Salunke, D. M. (2012). Limited conformational flexibility in the paratope may be responsible for degenerate specificity of HIV epitope recognition. International immunology, 25(2), 77-90.
Figure 3 Generation of the peptide-bound structures of KEL10 Fv. R
MSDs of the Cα atoms of the CDRs and peptide (A) and that of the whole KEL10 Fv and the peptide (B) during the 6 ns MD simulations of each of the peptide-bound Fv structures. In each case, the averaged structure from the last 4 ns run was energy minimized and used for further analysis. All the epitopes were found to bind in the same binding pocket as shown in (C). Stereoscopic representation of the superimposition of the different peptides in the antibody-bound conformation is shown in (D). The trajectories of the different peptide-bound structures and the peptides are coloured according to the legend.
Bhowmick, A., & Salunke, D. M. (2012). Limited conformational flexibility in the paratope may be responsible for degenerate specificity of HIV epitope recognition. International immunology, 25(2), 77-90.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-1889-sdAb | Recombinant Anti-HIV-1 VHH Single Domain Antibody | WB, ICC, ChiP, FA, ELISA | Llama VHH |
PNBL-038 | Recombinant Anti-HIV-1 C186 gp120 VHH Single Domain Antibody (A12) | WB, FuncS | Llama VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-068 | Anti-HIV-1 Recombinant Antibody (Suvizumab) | WB, ELISA, IP, FC, FuncS, Neut, IF | IgG1 - kappa |
PABX-094-S (P) | Recombinant Human Anti-HIV-1 Antibody scFv Fragment (Fab4025) | WB, ELISA, FuncS | scFv |
PABX-099-S (P) | Recombinant Human Anti-HIV-1 Antibody scFv Fragment | FC, FuncS | scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
AGTO-G037E | Anti-HIV-1 immunotoxin 3B3 (scFv)-PE | Cytotoxicity assay, Function study | |
AGTO-G037D | Anti-HIV-1 immunotoxin 3B3 (scFv)-DT | Cytotoxicity assay, Function study |
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-140 | Human Anti-HIV-1 Recombinant Antibody (clone VRC26.25); Fab Fragment | WB, ELISA, Neut, FuncS | Human Fab |
FAMAB-0176CQ-F(E) | Mouse Anti-HIV-1 Recombinant Antibody (clone KEL10); Fab Fragment | ELISA, Neut | Mouse Fab |
HPAB-0158-YJ-F(E) | Human Anti-HIV-1 Recombinant Antibody; Fab Fragment (HPAB-0158-YJ-F(E)) | ELISA, Neut, Inhib | Human Fab |
HPAB-AP363-YC-F(E) | Human Anti-HIV-1 Recombinant Antibody (clone A2); Fab Fragment | ELISA, Neut | Human Fab |
HPAB-1988-FY-F(E) | Human Anti-HIV-1 Recombinant Antibody (clone 2G9); Fab Fragment | FC, ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-770CQ | Mouse Anti-HIV-1 Recombinant Antibody (clone 10 (03-002)) | EIA, WB, IHC, IP | Mouse IgG1 |
HPAB-AP363-YC | Human Anti-HIV-1 Recombinant Antibody (clone A2) | FuncS, FC | Human IgG |
VS-0423-XY8 | Mouse Anti-HIV-1 Recombinant Antibody (clone CP503) | ELISA | Mouse IgG |
VS-0423-XY9 | Mouse Anti-HIV-1 Recombinant Antibody (clone CP506) | ELISA | Mouse IgG |
VS-0423-XY10 | Mouse Anti-HIV-1 Recombinant Antibody (clone CP507) | ELISA | Mouse IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-008 | Recombinant Mouse Anti-HIV-1 Antibody | WB, IHC, IF, FuncS | IgG |
PABX-084 | Recombinant Mouse Anti-HIV-1 Antibody (83.1) | WB, ELISA, FuncS | IgG |
PABX-089 | Recombinant Mouse Anti-HIV-1 Antibody (A10F9) | Neut, FuncS | IgG |
PABX-096-S (P) | Recombinant Human Anti-HIV-1 Antibody scFv Fragment (N12-i15) | WB, ELISA, IF, FuncS | scFv |
PABX-008-F (E) | Recombinant Mouse Anti-HIV-1 Antibody Fab Fragment | WB, IHC, IF, FuncS | Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-090 | Recombinant Human Anti-HIV-1 Antibody (CH04H/CH02L) | Neut, FuncS | IgG |
PABX-091 | Recombinant Human Anti-HIV-1 Antibody (Fab2219) | Neut, ELISA, FuncS | IgG |
PABX-092 | Recombinant Human Anti-HIV-1 Antibody (Fab2558) | WB, ELISA, Neut, FuncS | IgG |
PABX-094 | Recombinant Human Anti-HIV-1 Antibody (Fab4025) | WB, ELISA, FuncS | IgG |
PABX-096 | Recombinant Human Anti-HIV-1 Antibody (N12-i15) | WB, ELISA, IF, FuncS | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-093-S (P) | Recombinant Mouse Anti-HIV-1 Antibody scFv Fragment (Fab28) | WB, ELISA, FuncS | scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
MHC-LC1376 | PE-A*02:01/HIV-1 (SLFNTVATL) MHC Tetramer | FCM | |
MHC-LC1377 | APC-A*02:01/HIV-1 (SLFNTVATL) MHC Tetramer | FCM | |
MHC-LC1378 | BV421-A*02:01/HIV-1 (SLFNTVATL) MHC Tetramer | FCM |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-4221 | Rabbit Anti-HIV-1 Recombinant Antibody (clone SI300DS) | ELISA, ICC, IF, FC | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
FAMAB-0176CQ-S(P) | Mouse Anti-HIV-1 Recombinant Antibody (clone KEL10); scFv Fragment | ELISA, Neut | Mouse scFv |
HPAB-0158-YJ-S(P) | Mouse Anti-HIV-1 Recombinant Antibody; scFv Fragment (HPAB-0158-YJ-S(P)) | ELISA, Neut, Inhib | Mouse scFv |
HPAB-AP363-YC-S(P) | Human Anti-HIV-1 Recombinant Antibody (clone A2); scFv Fragment | ELISA, Neut | Human scFv |
HPAB-1988-FY-S(P) | Human Anti-HIV-1 Recombinant Antibody (clone 2G9); scFv Fragment | FC, ELISA | Human scFv |
HPAB-1989-FY-S(P) | Human Anti-HIV-1 Recombinant Antibody (clone 9F11); scFv Fragment | FC, ELISA | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-068 | Afuco™ Anti-HIV-1 ADCC Recombinant Antibody (Suvizumab), ADCC Enhanced | ELISA, IP, FC, FuncS, Neut | ADCC enhanced antibody |
There are currently no Customer reviews or questions for FAMAB-0176CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.